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Abstract
Metastatic presentation of leiomyosarcoma in the heart is very rare. We present transthoracic
echocardiography and combined PET/CT images of a case with a large right ventricular metastasis
of leiomyosarcoma. The patient was placed on cytostatic drugs for palliative purposes, but passed
away one month later because of an untreatable ventricular tackycardia.
Introduction
The word sarcoma is derived from the Greek word fleshy
substance, and this group of neoplasm constitutes a very
heterogeneous group [1]. Leiomyosarcoma of the uterus is
a rather uncommon tumor, accounts for only a few per-
cent of all cancers of the uterus, and is associated with
poor prognosis [1,2]. Leiomyosarcoma primarily tend to
metastasize to the peritoneal cavity, lung, lymph nodes, or
liver [3]. Metastatic manifestations of leiomyosarcoma to
the heart are very rare. There are only sporadic case reports
of imaging in cases with leiomyosarcoma metastasis to
the heart, and none include images from echocardiogra-
phy and PET/CT [4-8]. The present case report includes
transthoracic echocardiography and combined PET/CT
images of a large right ventricular metastasis of leiomyosa-
rcoma.
Case presentation
The patient was a 69-year-old woman who 3-years earlier
had undergone surgical resection of a leiomyosarcoma
located in the corpus uteri. A recent chest X-ray had
showed a tumor-suspected structure in the left lung. This
was shown by fine needle biopsy to be a metastatic tumor
of leiomyosarcoma. For primary tumor staging the patient
underwent a combined computed positron emission tom-
ography (PET) and computer tomography (CT) examina-
tion by an integrated PET/CT system (Gemini TF, Philips
Medical Systems, Best, the Netherlands), after injection of
18F-fluorodeoxyglucose (FDG) [2]. Figure 1 displays a CT
image that shows the rather large tumor located in the
right ventricle and appears to engage the interventricu-
larseptum. Figure 2 shows the corresponding PET image.
Additional metastases were also found in both lungs.
Standard transthoracic echocardiography examination
was performed, as part of a cardiac evaluation, with a
Sonos 5500 (Philips Medical Systems, Andover, Massa-
chusetts, USA). A predominantly echodense structure was
visualised in the apical portion of the right ventricle, from
an apical four-chamber view (Figure 3 and Additional file
1). The structure measured approximately 5 × 3 centime-
tres and was occupying the apical half of the right ven-
tricular cavity. The contraction of the
interventricularseptum was significantly reduced presum-
ably due to tumor growth into the interventricularseptum
(Additional files 1, 2 &3). Stroke volume measurement by
Doppler indicated a stroke volume from the right ventri-
cle of 86 ml. The patient was placed on cytostatic drugs for
palliative purposes, but passed away one month later
because of an untreatable ventricular tackycardia.
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Discussion
The present case report includes transthoracic echocardi-
ography and combined PET/CT images of a rare case with
a large right ventricular metastasis of leiomyosarcoma.
Metastatic manifestations of a leiomyosarcoma to the
heart are associated with very poor prognosis and our
patient passed away only one month later because of an
untreatable ventricular tackycardia. The use of a radiop-
harmaceutical agent such as FDG provides the capability
for imaging tumor glucose metabolism, whereas CT
images provide anatomical information [9]. The CT
images indicated that the tumor was growing through the
septum. This could, however, be due to motion artifacts
since the image acquisition was not ECG-gated. The image
of FDG uptake indicated, for a malignant tumor, moder-
ately elevated uptake in the rim of the tumor, as expected
for a leiomyosarcoma [2], whereas the centre of the tumor
displayed no uptake thus suggesting necrosis. Further-
more, there was a significant reduction of glucose uptake
in the septum, compared to the lateral wall, which was
probably due to tumor growth. This hypothesis was sup-
ported by the fact that the contraction of the interventricu-
larseptum was significantly reduced, presumably due to
the tumor growth into the interventricularseptum. It is
also of interest that the cardiac output of the right ventri-
cle was preserved at rest in our case, despite the fact that
almost 50% of the right ventricular lumen was obliterated
by the metastasis of the leiomyosarcoma.
The echocardiography diagnosis of a tumor within the
heart is not always straightforward [10]. Differential diag-
nosis that should be considered, apart from metastasis,
include primary cardiac tumor -primarily myxoma, vege-
tation, or thrombus. Assessing the location of the mass
combined with echogenicity of the mass, and naturally
including patient history often result in a accurate diagno-
sis. While it has been suggested that contrast echocardiog-
raphy improves the diagnostic capacity of transthoracic
echocardiography examination with respect to differenti-
ating intracardiac masses [11,12], the evidence for this is
scarce. The only reasonably large study was performed by
Kirkpatrick and co-workers, who investigated this hypoth-
esis examining a series of 16 patients with cardiac masses
[12]. The highest pixel intensity was found in patients
with malignant tumor growth, the lowest in patients with
thrombus, and middle pixel intensity was found in
patients with benign tumors. The overlap in pixel inten-
sity was rather significant. We did not use echo contrast in
this patient since the diagnosis was known and the pur-
pose of the echocardiography examination was to evalu-
Display of CT-image Figure 1
Display of CT-image. The yellow arrow indicates the 
metastasis of the leiomyosarcoma. The red arrow indicates 
of the lung metastases.
Display of PET-image Figure 2
Display of PET-image. The yellow arrow indicates the 
metastasis of the leiomyosarcoma. Note the absence of FDG 
uptake in the center of the tumor, thus suggesting necrosis. 
The red arrow indicates of the lung metastases.
Display of echocardiography image from apical four-chamber  view Figure 3
Display of echocardiography image from apical four-
chamber view. The yellow arrow indicates the metastasis 
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ate cardiac function. Most physicians considered
transesophageal echocardiography is by the method of
choice for optimal visualisation of heart morphology.
Transesophageal echocardiography was not performed in
our patient because of adequate acoustic windows and
because the purpose of the examination was to evaluate
cardiac function. Cardiac MRI has in recent years emerged
as an excellent tool in diagnosing space-occupying lesions
within or in the proximity of the heart [13,14], and has
the advantage over CT of not including ionizing radiation
or nephrotoxic contrast media. Cardiac MRI could, there-
fore, play an important role when echocardiography is
not conclusive.
There is naturally no consensus or any guidelines for the
optimal management of patients with ventricular metas-
tasis of leiomyosarcoma. Surgical resection has been
attempted in some cases [4,5], and this could be an option
if the tumor growth is restricted in its growth pattern and
if the patient is a candidate for surgery. This was consid-
ered unrealistic in our patient due to the infiltrative
growth of the tumor in the heart combined with multiple
metastases.
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Additional File 1
Movie 1. Movie of echocardiography examination from an apical four-
chamber view. Note the significant reduction of contractility in the inter-
ventricularseptum, presumably due to tumor growth.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-7-20-S1.avi]
Additional File 2
Movie 2. Movie from a parasternal long-axis view that show tumor engag-
ing the interventricularseptum.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-7-20-S2.avi]
Additional File 3
Movie 3. Movie from a parasternal short-axis view that show the obliter-
ation of the right ventricular cavity because of tumor growth.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-7-20-S3.avi]